JPS5417107A - Treating agent of abnormal progress - Google Patents

Treating agent of abnormal progress

Info

Publication number
JPS5417107A
JPS5417107A JP5987378A JP5987378A JPS5417107A JP S5417107 A JPS5417107 A JP S5417107A JP 5987378 A JP5987378 A JP 5987378A JP 5987378 A JP5987378 A JP 5987378A JP S5417107 A JPS5417107 A JP S5417107A
Authority
JP
Japan
Prior art keywords
treating agent
abnormal progress
abnormal
progress
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5987378A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6341890B2 (enExample
Inventor
Ruuensutorotsutoob Geeruharuto
Shieereru Rainaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Original Assignee
Max Planck Gesellschaft zur Foerderung der Wissenschaften
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19772722769 external-priority patent/DE2722769C3/de
Priority claimed from DE2750920A external-priority patent/DE2750920C3/de
Application filed by Max Planck Gesellschaft zur Foerderung der Wissenschaften filed Critical Max Planck Gesellschaft zur Foerderung der Wissenschaften
Publication of JPS5417107A publication Critical patent/JPS5417107A/ja
Publication of JPS6341890B2 publication Critical patent/JPS6341890B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2006—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP5987378A 1977-05-20 1978-05-19 Treating agent of abnormal progress Granted JPS5417107A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19772722769 DE2722769C3 (de) 1977-05-20 1977-05-20 Verwendung von Fibrinogen
DE2750920A DE2750920C3 (de) 1977-11-15 1977-11-15 Verwendung von Fibrinopeptiden A und B

Publications (2)

Publication Number Publication Date
JPS5417107A true JPS5417107A (en) 1979-02-08
JPS6341890B2 JPS6341890B2 (enExample) 1988-08-19

Family

ID=25772044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP5987378A Granted JPS5417107A (en) 1977-05-20 1978-05-19 Treating agent of abnormal progress

Country Status (4)

Country Link
US (1) US4215109A (enExample)
JP (1) JPS5417107A (enExample)
CH (1) CH644762A5 (enExample)
GB (1) GB1603244A (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104639A (en) * 1980-01-14 1992-04-14 Esa, Inc. Method for biological testing and/or developing pharmaceuticals for treatment of disorders using electrochromatography
US6333160B1 (en) 1988-08-31 2001-12-25 Keiji Tamura Method and specific diagnostic system for objectively assessing and monitoring the relative homeostasis and health of animals
ES2114654T3 (es) * 1993-06-08 1998-06-01 Vertex Pharma Piridazinas como inhibidores de la enzima de conversion de la interleuquina-1beta.
US7605132B2 (en) * 2001-08-29 2009-10-20 Yissum Research Development Company Of The Hebrew University Of Jerusalem Protective factors against inflammation, burns and noxious stimuli
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3973001A (en) * 1954-04-27 1976-08-03 Solco Basel Ag Tissue cell stimulating blood extracts
US2847349A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Plasma preparation
US2847348A (en) * 1954-05-27 1958-08-12 Ortho Pharma Corp Plasma fractionation and product therefrom
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US3717708A (en) * 1968-10-24 1973-02-20 Cutter Lab Blood coagulation complex
US3664994A (en) * 1969-06-30 1972-05-23 Upjohn Co Process for separating horse gamma globulin fractions by chromatography
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
US4073886A (en) * 1973-01-30 1978-02-14 Baxter Travenol Laboratories, Inc. Blood fractionation process using block copolymers of ethylene oxide and polyoxypropylene
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
US3893990A (en) * 1973-04-05 1975-07-08 Baxter Laboratories Inc Clarification of blood serum and plasma using a block copolymer of ethylene oxide and polyoxypropylene
US3893991A (en) * 1973-04-05 1975-07-08 Baxter Laboratories Inc Clarification of blood serum and plasma using block copolymers of ethylene oxide and polyoxypropylene
US3973002A (en) * 1974-04-12 1976-08-03 E. R. Squibb & Sons, Inc. Antihemophilic factor
JPS5176418A (en) * 1974-12-26 1976-07-02 Teijin Ltd Menekiguroburinno seizoho
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
CA1064396A (en) * 1975-02-18 1979-10-16 Myer L. Coval Fractional precipitation of gamma globulin with polyethylene glycol
US4087415A (en) * 1976-06-09 1978-05-02 William L. Wilson Antithrombin III
US4081432A (en) * 1977-07-25 1978-03-28 Monsanto Company Method of separating a Factor IX preparation from plasma using ethylene-maleic anhydride polymers

Also Published As

Publication number Publication date
JPS6341890B2 (enExample) 1988-08-19
GB1603244A (en) 1981-11-18
US4215109A (en) 1980-07-29
CH644762A5 (de) 1984-08-31

Similar Documents

Publication Publication Date Title
JPS53113762A (en) Treatment of sulfurrcontaining gas
PH24427A (en) Treatment of dysmanorrhea
JPS5479136A (en) Treatment of metal parts
JPS53109578A (en) Surface treating of polyfluorinatedvinyl
JPS53144495A (en) Method of treating claddforming material
GB2003057B (en) Treatment of iron
GB2006048B (en) Treatment of scarp
JPS5417107A (en) Treating agent of abnormal progress
JPS5480429A (en) Tooth treating agent
GB2015601B (en) Treatment of timber
GB2003206B (en) Treatment of timber
JPS53100653A (en) Sludge treating agent
JPS549453A (en) Method of treating nighttsoil
ZA781161B (en) Treatment of asthma
JPS53127835A (en) Treating agent for burn
JPS5415091A (en) Fiber treating agent
JPS5413427A (en) Treatment of drill surfaxe
JPS53136509A (en) Production of dermatophytosis treating agent
GB2002725B (en) Treatment of minestone
JPS5456907A (en) Heat treating of steel
JPS5459474A (en) Removing of excessive treating solution
ZA784438B (en) Treatment of textiles
JPS53109960A (en) Treating of sugar solution
JPS53127811A (en) Treating agent for cirhosis of liver
GB2005670B (en) Treatment of methactolein-containing gases